Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 May 27;100(11):6658-63.
doi: 10.1073/pnas.1135726100. Epub 2003 May 9.

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

Affiliations

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

Marisa Benagiano et al. Proc Natl Acad Sci U S A. .

Abstract

Atherosclerotic lesions are infiltrated by macrophages and T lymphocytes, potentially reactive to pathogens. We studied in vivo activated T lymphocytes that infiltrate atherosclerotic plaques of Helicobacter pylori-infected patients with or without anti-Chlamydia pneumoniae antibodies. In all atherosclerotic lesions, T helper type 1 (Th1) cells were predominant. C. pneumoniae-specific T cells were detected only in the plaques of anti-C. pneumoniae seropositive patients, whereas H. pylori-specific T cells were found in the gastric mucosa but not in the plaques of the same patients. Plaque-derived Th1 cells expressed cytotoxicity, proapoptotic activity, and help for monocyte tissue factor production. Although multifactorial, atherosclerosis can be regarded as a Th1-driven immunopathological condition.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Cytokine profile of the T cell clones derived from atherosclerotic plaques. Plaque-derived T cell clones were obtained from 10 H. pylori-infected patients, five of whom (A–E) were seropositive for anti-C. pneumoniae antibodies, whereas the other five (F–K) were seronegative. Duplicate samples of supernatants of mitogen-stimulated T cell clones were assayed for cytokine production. CD4+ and CD8+ clones able to produce IFN-γ, but not IL-4, were categorized as Thl and Tc1, whereas CD4+ and CD8+ clones producing both IFN-γ and IL-4 were coded as Th0 and Tc0, respectively.
Fig. 2.
Fig. 2.
Antigen repertoire of plaque-infiltrating T cell clones reactive to C. pneumoniae. Th1 and Th0 clones were tested for proliferation to C. pneumoniae EB (Cp EB), recombinant C. pneumoniae HSP-60, HSP-10, and OMP-2 in the presence of irradiated autologous APCs.
Fig. 3.
Fig. 3.
C. pneumoniae antigen-induced cytokine production by plaque-infiltrating T cell clones. C. pneumoniae-specific Th1 or Th0 clones were stimulated with the appropriate antigen, and IFN-γ, TNF-α, IL-4, and IL-5 production was measured in culture supernatants. In unstimulated control cultures, levels of IFN-γ, TNF-α, IL-4, and IL-5 were consistently <0.05 ng/ml.
Fig. 4.
Fig. 4.
Cytotoxic and proapoptotic activity of C. pneumoniae-specific plaque-infiltrating T cells. (A) To assess their perforin-mediated cytotoxicity, C. pneumoniae-specific T cell clones were cocultured at different effector-to-target ratios with 51Cr-labeled autologous EBV-B cells pulsed with C. pneumoniae EB (▴) or H. pylori lysate (▵), and 51Cr release was measured as index of specific target cell lysis. (B) To assess their ability to induce apoptosis in target cells, C. pneumoniae-specific T cell clones stimulated with mitogen (▪) or medium alone (□) were cocultured with 51Cr-labeled Fas+ Jurkat cells, and 51Cr release was measured as index of apoptotic target cell death. Data of three representative clones are reported.
Fig. 5.
Fig. 5.
C. pneumoniae-specific T cells induce TF production by monocytes. To assess their ability to induce TF production by monocytes, C. pneumoniae-specific Th1 and Th0 clones were cocultured with autologous monocytes in the presence of medium or C. pneumoniae EB, and TF production by monocytes was assessed by an appropriate ELISA.

Similar articles

Cited by

References

    1. Ross, R. (1999) N. Engl. J. Med. 340, 115–126. - PubMed
    1. Epstein, S. E., Zhou, Y. F. & Zhu, J. (1999) Circulation 100, 20–28. - PubMed
    1. Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. (1986) Arteriosclerosis 6, 131–138. - PubMed
    1. Hansson, G. K., Jonasson, L., Seifert, P. S. & Stemme, S. (1989) Arteriosclerosis 9, 567–578. - PubMed
    1. Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W. & Meyer, J. (2002) Circulation 105, 15–21. - PubMed

Publication types

LinkOut - more resources